ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v14i4.1769ppharm-1546Research ArticleМНЕНИЕ ПО ПРОБЛЕМЕPROBLEMS. EXPERT OPINIONМнение аллергологаThe Allergist’s Point of Viewhttps://orcid.org/0000-0002-1589-5623ЛевинаЮ. Г.LevinaYuliya G.

кандидат медицинских наук, врач-аллерголог отделения восстановительного лечения детей с аллергическими болезнями и заболеваниями органов дыхания Национального медицинского исследовательского центра здоровья детей Минздрава России

Адрес: 119991, Москва, Ломоносовский проспект, д. 2, тел.: +7 (499) 134-03-92

levina@nczd.ruНациональный медицинский исследовательский центр здоровья детейРоссияNational Medical Research Center of Children’s HealthRussian Federation201705102017144317319Copyright © Левина Ю.Г., 20172017Левина Ю.Г.Levina Y.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/1546

.

.

ReferencesCates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta- agonist treatment of acute asthma. Cochrane Database Syst Rev. 2006;(2):CD000052. doi: 10.1002/14651858.CD000052.pub2.Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta- agonist treatment of acute asthma. Cochrane Database Syst Rev. 2006;(2):CD000052. doi: 10.1002/14651858.CD000052.pub2.Федеральные клинические рекомендации по оказанию медицинской помощи детям с бронхиальной астмой. — М.: Союз педиатров России; 2016. — 33 с. [Federal’nye klinicheskie rekomendatsii po okazaniyu meditsinskoi pomoshchi detyam s bronkhial’noi astmoi. Moscow: Soyuz pediatrov Rossii; 2016. 33 p. (In Russ).]Федеральные клинические рекомендации по оказанию медицинской помощи детям с бронхиальной астмой. — М.: Союз педиатров России; 2016. — 33 с. [Federal’nye klinicheskie rekomendatsii po okazaniyu meditsinskoi pomoshchi detyam s bronkhial’noi astmoi. Moscow: Soyuz pediatrov Rossii; 2016. 33 p. (In Russ).]Fayaz M, Sultan A, Rai ME. Comparison between efficacy of MDI+spacer and nebuliser in the management of acute asthma in children. J Ayub Med Coll Abbottabad. 2009;21(1):32– 34.Fayaz M, Sultan A, Rai ME. Comparison between efficacy of MDI+spacer and nebuliser in the management of acute asthma in children. J Ayub Med Coll Abbottabad. 2009;21(1):32– 34.Breuer O, Shoseyov D, Kerem E, Brooks R. Implementation of a policy change: replacement of nebulizers by spacers for the treatment of asthma in children. Isr Med Assoc J. 2015;17(7):421–424.Breuer O, Shoseyov D, Kerem E, Brooks R. Implementation of a policy change: replacement of nebulizers by spacers for the treatment of asthma in children. Isr Med Assoc J. 2015;17(7):421–424.Laube BL, Janssens HM, de Jongh FH, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37(6):1308–1331. doi: 10.1183/09031936.00166410.Laube BL, Janssens HM, de Jongh FH, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37(6):1308–1331. doi: 10.1183/09031936.00166410.Селимзянова Л.Р., Вишнёва Е.А., Промыслова Е.А. Принципы диагностики и терапии бронхиальной астмы у детей на современном этапе: обзор обновлений GINA 2014– 2015 // Педиатрическая фармакология. — 2015. — Т.12. — №3 — С. 290–295. [Selimzyanova LR, Vishneva EA, Promyslova EA. Principles of diagnosis and therapy of bronchial asthma in children at the present stage: GINA 2014–2015 review updates. Pediatric pharmacology. 2015;12(3):290–295. (In Russ).] doi: 10.15690/pf.v12i3.1353.Селимзянова Л.Р., Вишнёва Е.А., Промыслова Е.А. Принципы диагностики и терапии бронхиальной астмы у детей на современном этапе: обзор обновлений GINA 2014– 2015 // Педиатрическая фармакология. — 2015. — Т.12. — №3 — С. 290–295. [Selimzyanova LR, Vishneva EA, Promyslova EA. Principles of diagnosis and therapy of bronchial asthma in children at the present stage: GINA 2014–2015 review updates. Pediatric pharmacology. 2015;12(3):290–295. (In Russ).] doi: 10.15690/pf.v12i3.1353.Erzinger S, Schueepp KG, Brooks-Wildhaber J, et al. Face masks and aerosol delivery in vivo. J Aerosol Med. 2007;20 Suppl 1:S78– S84. doi: 10.1089/jam.2007.0572.Erzinger S, Schueepp KG, Brooks-Wildhaber J, et al. Face masks and aerosol delivery in vivo. J Aerosol Med. 2007;20 Suppl 1:S78– S84. doi: 10.1089/jam.2007.0572.Brand PL. Inhalation therapy in children with asthma. Minerva Pediatr. 2000;52(3):137–142.Brand PL. Inhalation therapy in children with asthma. Minerva Pediatr. 2000;52(3):137–142.Cates CJ, Bestall J, Adams N. Holding chambers versus nebulisers for inhaled steroids in chronic asthma. Cochrane Database Syst Rev. 2006;(1):CD001491. doi: 10.1002/14651858.CD001491.pub2.Cates CJ, Bestall J, Adams N. Holding chambers versus nebulisers for inhaled steroids in chronic asthma. Cochrane Database Syst Rev. 2006;(1):CD001491. doi: 10.1002/14651858.CD001491.pub2.Boe J, Dennis JH, O’Driscoll BR, et al. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J. 2001;18(1):228–242. doi: 10.1183/09031936.01.00220001.Boe J, Dennis JH, O’Driscoll BR, et al. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J. 2001;18(1):228–242. doi: 10.1183/09031936.01.00220001.Rau JL. Design principles of liquid nebulization devices currently in use. Respir Care. 2002;47(11):1257–1275.Rau JL. Design principles of liquid nebulization devices currently in use. Respir Care. 2002;47(11):1257–1275.Butz AM, Eggleston P, Huss K, et al. Children with asthma and nebulizer use: parental asthma self-care practices and beliefs. J Asthma. 2001;38(7):565–573. doi: 10.1081/Jas-100107121.Butz AM, Eggleston P, Huss K, et al. Children with asthma and nebulizer use: parental asthma self-care practices and beliefs. J Asthma. 2001;38(7):565–573. doi: 10.1081/Jas-100107121.

The authors declare that there are no conflicts of interest present.